Targeting Glioblastoma: Efficacy of Ruthenium-Based Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Glioblastoma: Efficacy of Ruthenium-Based Drugs

Published:2024-08-20 Issue: Volume: Page:
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Rasin Puthiyavalappil¹,Surendran Sravan Sangeeth²,K S Karthik²,Haribabu Jebiti³^ORCID,Sreekanth Anandaram²^ORCID

Affiliation:

1. Center for Nonlinear Systems, Chennai Institute of Technology (CIT), Chennai 600069, India

2. Department of Chemistry, National Institute of Technology, Tiruchirappalli, Tamil Nadu 620015, India

3. ATACAMA-OMICS, Facultad de Medicine, Universidad de Atacama, Los Carreras 1579, 1532502 Copiapo, Chile

Funder

Universidad de Atacama

Ministry of Human Resource Development

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.chemrestox.4c00188

Reference9 articles.

1. Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity

2. Development of novel ruthenium(ii)–arene complexes displaying potent anticancer effects in glioblastoma cells

3. Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade

4. Target based chemotherapeutic advancement of ruthenium complexes

5. Transferrin Serves As a Mediator to Deliver Organometallic Ruthenium(II) Anticancer Complexes into Cells

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP